ఎండోక్రినాలజీ & మెటాబాలిక్ సిండ్రోమ్
అందరికి ప్రవేశం

నైరూప్య

The Overall Evolution of Lebanese Patients with Type 2 Diabetes Over 5 Years: A Comparison from the International Diabetes Management Practices Study Results

Zreik R, El Ghandour S, Sawaya MT, Al-Badri MR and Azar ST

Type 2 Diabetes is a worldwide epidemic. Similar to other Western and Middle Eastern countries, many efforts are being made in Lebanon to study the characteristics of the population with type 2 Diabetes with the aim of optimizing treatment and preventing late complications. This study is a description of the evolution of the control of patients with type 2 Diabetes in Lebanon, over a 5 years period. 1285 and 1059 patients with type 2 Diabetes were recruited with a mean BMI in the overweight range. Their mean FBG decreased from 10.63 ± 4.06 mmol/L in 2006 to 8.54 ± 3.49 mmol/L in 2011. The mean duration of diabetes was 8.11 ± 7.23 years, comparable in 2006 and 2011. The mean HbA1c decreased from 8.1% (65 mmol/mol) to 7.8% (62 mmol/mol) in 2011, with 36.1% of patients reaching the target range